Susquehanna Portfolio Strategies, LLC Blueprint Medicines Corp Transaction History
Susquehanna Portfolio Strategies, LLC
- $2.43 Trillion
- Q2 2024
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 40,277 shares of BPMC stock, worth $3.62 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
40,277
Previous 97,817
58.82%
Holding current value
$3.62 Million
Previous $9.28 Billion
53.22%
% of portfolio
0.18%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding BPMC
# of Institutions
340Shares Held
62MCall Options Held
987KPut Options Held
578K-
Black Rock Inc. New York, NY6.65MShares$598 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.54MShares$588 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.87MShares$529 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$291 Million0.06% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.46MShares$221 Million8.22% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.37B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...